BOULDER, Colo.--Genomica has sold the first US license for its Discovery Manager bioinformatics application to Glaxo Wellcome. The sale closely followed Genomica's first ever license sale, to Oxagen in Oxford, UK.
Thomas Marr, president and CEO of Genomica, noted, "This is the first big pharmaceutical company, so it is very exciting." He said Glaxo's genetics department had been beta-testing Discovery Manager. When the test ended, Glaxo decided to buy the software.